Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 96 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Comparing social reciprocity in preserved speech variant and typical Rett syndrome during the early years of life.

    Townend GS, Bartl-Pokorny KD, Sigafoos J, et al.

    Research in developmental disabilities 2015; (43-44()):80-6.

    PMID: 26159884
  2. 2

    The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.

    Tarquinio DC, Hou W, Neul JL, et al.

    Pediatric neurology 2015; (53(5)):402-11.

    PMID: 26278631
  3. 3

    A RETT SYNDROME CASE WITH NOVEL NON-IDENTICAL MUTATION IN MECP2 GENE.

    Güngör O, Kirik S, Cevizli D, et al.

    Genetic counseling (Geneva, Switzerland) 2015; (26(4)):387-92.

    PMID: 26852508
  4. 4

    MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.

    Zahorakova D, Lelkova P, Gregor V, et al.

    Journal of human genetics 2016; (61(7)):617-25 doi:10.1038/jhg.2016.19.

    PMID: 26984561
  5. 5

    Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells.

    Andoh-Noda T, Inouye MO, Miyake K, et al.

    CNS & neurological disorders drug targets 2016; (15(5)):544-50 doi:10.2174/1871527315666160413120156.

    PMID: 27071793
  6. 6

    Clapping-surpressed focal spikes in EEG may be unique for the patients with rett syndrome : a case report.

    Lv Y, Liu C, Shi M, Cui L

    BMC neurology 2016; (16()):91 doi:10.1186/s12883-016-0613-4.

    PMID: 27296050
  7. 7

    Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.

    Ehrhart F, Coort SL, Cirillo E, et al.

    Orphanet journal of rare diseases 2016; (11(1)):158 doi:10.1186/s13023-016-0545-5.

    PMID: 27884167
  8. 8

    4-hydroxynonenal protein adducts: Key mediator in Rett syndrome oxinflammation.

    Valacchi G, Pecorelli A, Cervellati C, Hayek J

    Free radical biology & medicine 2017; (111()):270-280 doi:10.1016/j.freeradbiomed.2016.12.045.

    PMID: 28063942
  9. 9

    Variations of stereotypies in individuals with Rett syndrome: A nationwide cross-sectional study in Taiwan.

    Chin Wong L, Hung PL, Jan TY, et al.

    Autism research : official journal of the International Society for Autism Research 2017; (10(7)):1204-1214 doi:10.1002/aur.1774.

    PMID: 28272783
  10. 10

    Sustained attention in the face of distractors: A study of children with Rett syndrome.

    Rose SA, Wass S, Jankowski JJ, et al.

    Neuropsychology 2017; (31(4)):403-410 doi:10.1037/neu0000369.

    PMID: 28383972
  11. 11

    FOXG1 Mutation is a Low-Incidence Genetic Cause in Atypical Rett Syndrome.

    Byun CK, Lee JS, Lim BC, et al.

    Child neurology open 2015; (2(1)):2329048X14568151 doi:10.1177/2329048X14568151.

    PMID: 28503589
  12. 12

    An Atypical Rett Syndrome Phenotype Due to a Novel Missense Mutation in CACNA1A.

    Epperson MV, Haws ME, Standridge SM, Gilbert DL

    Journal of child neurology 2018; (33(4)):286-289 doi:10.1177/0883073818754987.

    PMID: 29366381
  13. 13

    MECP2 mutation in a boy with severe apnea and sick sinus syndrome.

    Shioda T, Takahashi S, Kaname T, et al.

    Brain & development 2018; (40(8)):714-718 doi:10.1016/j.braindev.2018.03.008.

    PMID: 29631775
  14. 14

    Whole exome sequencing identifies a novel 5 Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures.

    Vineeth VS, Dutta UR, Tallapaka K, et al.

    Gene 2018; (673()):56-60 doi:10.1016/j.gene.2018.06.045.

    PMID: 29920362
  15. 15

    Epilepsy in classic Rett syndrome: Course and characteristics in adult age.

    Henriksen MW, Breck H, von Tetzchner S, et al.

    Epilepsy research 2018; (145()):134-139 doi:10.1016/j.eplepsyres.2018.06.012.

    PMID: 29966812
  16. 16

    Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.

    SoRelle JA, Thodeson DM, Arnold S, et al.

    JAMA pediatrics 2019; (173(1)):e182302 doi:10.1001/jamapediatrics.2018.2302.

    PMID: 30398534
  17. 17

    Psychomotor Dysfunction in Rett Syndrome: Insights into the Neurochemical and Circuit Roots.

    Liao W

    Developmental neurobiology 2019; (79(1)):51-59 doi:10.1002/dneu.22651.

    PMID: 30430747
  18. 18

    The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

    Neul JL, Benke TA, Marsh ED, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2019; (180(1)):55-67 doi:10.1002/ajmg.b.32707.

    PMID: 30536762
  19. 19

    Biliary Tract Disease in Girls and Young Women With Rett Syndrome.

    Motil KJ, Lane JB, Barrish JO, et al.

    Journal of pediatric gastroenterology and nutrition 2019; (68(6)):799-805 doi:10.1097/MPG.0000000000002273.

    PMID: 30664568
  20. 20

    Attentional shifting and disengagement in Rett syndrome.

    Rose SA, Wass S, Jankowski JJ, et al.

    Neuropsychology 2019; (33(3)):335-342 doi:10.1037/neu0000515.

    PMID: 30688490
  21. 21

    Rett syndrome: from recognition to diagnosis to intervention.

    Percy AK

    Expert review of endocrinology & metabolism 2008; (3(3)):327-336 doi:10.1586/17446651.3.3.327.

    PMID: 30754201
  22. 22

    Treating Rett syndrome: from mouse models to human therapies.

    Vashi N, Justice MJ

    Mammalian genome : official journal of the International Mammalian Genome Society 2019; (30(5-6)):90-110 doi:10.1007/s00335-019-09793-5.

    PMID: 30820643
  23. 23

    Epilepsy and genetic in Rett syndrome: A review.

    Operto FF, Mazza R, Pastorino GMG, et al.

    Brain and behavior 2019; (9(5)):e01250 doi:10.1002/brb3.1250.

    PMID: 30929312
  24. 24

    Hand stereotypies: Lessons from the Rett Syndrome Natural History Study.

    Stallworth JL, Dy ME, Buchanan CB, et al.

    Neurology 2019; (92(22)):e2594-e2603 doi:10.1212/WNL.0000000000007560.

    PMID: 31053667
  25. 25

    Using directed-content analysis to identify a framework for understanding quality of life in adults with Rett syndrome.

    Strugnell A, Leonard H, Epstein A, Downs J

    Disability and rehabilitation 2020; (42(26)):3800-3807 doi:10.1080/09638288.2019.1610801.

    PMID: 31074665
  26. 26

    Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges.

    Vidal S, Xiol C, Pascual-Alonso A, et al.

    International journal of molecular sciences 2019; (20(16)) doi:10.3390/ijms20163925.

    PMID: 31409060
  27. 27

    Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.

    Kadam SD, Sullivan BJ, Goyal A, et al.

    International journal of molecular sciences 2019; (20(20)) doi:10.3390/ijms20205098.

    PMID: 31618813
  28. 28

    Clinical Feature and Genetics in Rett Syndrome: A Report on Iranian Patients.

    Karimzadeh P, Kheirollahi M, Houshmand SM, et al.

    Iranian journal of child neurology 2019; (13(4)):37-51.

    PMID: 31645865
  29. 29

    Compromised immune/inflammatory responses in Rett syndrome.

    Pecorelli A, Cervellati C, Cordone V, et al.

    Free radical biology & medicine 2020; (152()):100-106 doi:10.1016/j.freeradbiomed.2020.02.023.

    PMID: 32119978
  30. 30

    Genetic and clinical variations in a Norwegian sample diagnosed with Rett syndrome.

    Henriksen MW, Breck H, Sejersted Y, et al.

    Brain & development 2020; (42(7)):484-495 doi:10.1016/j.braindev.2020.03.008.

    PMID: 32336485
  31. 31

    MECP2 mutation spectrum and its clinical characteristics in a Chinese cohort.

    Wen Y, Wang J, Zhang Q, et al.

    Clinical genetics 2020; (98(3)):240-250 doi:10.1111/cge.13790.

    PMID: 32472557
  32. 32

    Dental procedure under opioid-free balanced anaesthesia in a child with Rett syndrome who convulsed on every attempt to feed: Case report.

    Ponde V, Desai A, Ekambaram K, Thakur S

    Indian journal of anaesthesia 2020; (64(4)):325-327 doi:10.4103/ija.IJA_812_19.

    PMID: 32489209
  33. 33

    Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

    Katayama S, Sueyoshi N, Inazu T, Kameshita I

    Neural plasticity 2020; (2020()):6970190 doi:10.1155/2020/6970190.

    PMID: 32587608
  34. 34

    Consensus guidelines on managing Rett syndrome across the lifespan.

    Fu C, Armstrong D, Marsh E, et al.

    BMJ paediatrics open 2020; (4(1)):e000717 doi:10.1136/bmjpo-2020-000717.

    PMID: 32984552
  35. 35

    Multisystem comorbidities in classic Rett syndrome: a scoping review.

    Fu C, Armstrong D, Marsh E, et al.

    BMJ paediatrics open 2020; (4(1)):e000731 doi:10.1136/bmjpo-2020-000731.

    PMID: 33024833
  36. 36

    A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance.

    Lee HM, Kuijer MB, Ruiz Blanes N, et al.

    Journal of neurodevelopmental disorders 2020; (12(1)):29 doi:10.1186/s11689-020-09332-3.

    PMID: 33172406
  37. 37

    Oral Manifestations of Rett Syndrome-A Systematic Review.

    Mahdi SS, Jafri HA, Allana R, et al.

    International journal of environmental research and public health 2021; (18(3)) doi:10.3390/ijerph18031162.

    PMID: 33525609
  38. 38

    Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.

    Rizk M, Saker Z, Harati H, et al.

    Molecular biology reports 2021; (48(3)):2669-2686 doi:10.1007/s11033-021-06237-9.

    PMID: 33650079
  39. 39

    Novel Mutations of the TYMP Gene in Mitochondrial Neurogastrointestinal Encephalomyopathy: Case Series and Literature Review.

    Mojtabavi H, Fatehi F, Shahkarami S, et al.

    Journal of molecular neuroscience : MN 2021; (71(12)):2526-2533 doi:10.1007/s12031-021-01822-w.

    PMID: 33825174
  40. 40

    Measures of attention in Rett syndrome: Internal consistency reliability.

    Rose SA, Wass SV, Jankowski JJ, Djukic A

    Neuropsychology 2021; (35(6)):595-608 doi:10.1037/neu0000744.

    PMID: 34096738
  41. 41

    Altered Bone Status in Rett Syndrome.

    Pecorelli A, Cordone V, Schiavone ML, et al.

    Life (Basel, Switzerland) 2021; (11(6)) doi:10.3390/life11060521.

    PMID: 34205017
  42. 42

    Decline in gross motor skills in adult Rett syndrome; results from a Danish longitudinal study.

    Bisgaard AM, Wong K, Højfeldt AK, et al.

    American journal of medical genetics. Part A 2021; (185(12)):3683-3693 doi:10.1002/ajmg.a.62429.

    PMID: 34296518
  43. 43

    Rett syndrome: think outside the (skull) box.

    Borloz E, Villard L, Roux JC

    Faculty reviews 2021; (10()):59 doi:10.12703/r/10-59.

    PMID: 34308425
  44. 44

    Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.

    Spagnoli C, Fusco C, Pisani F

    Genes 2021; (12(8)) doi:10.3390/genes12081157.

    PMID: 34440332
  45. 45

    MECP2-Related Disorders in Males.

    Pascual-Alonso A, Martínez-Monseny AF, Xiol C, Armstrong J

    International journal of molecular sciences 2021; (22(17)) doi:10.3390/ijms22179610.

    PMID: 34502518
  46. 46

    Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.

    Bach S, Shovlin S, Moriarty M, et al.

    Frontiers in cellular neuroscience 2021; (15()):764761 doi:10.3389/fncel.2021.764761.

    PMID: 34867203
  47. 47

    Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.

    Neul JL, Percy AK, Benke TA, et al.

    Contemporary clinical trials 2022; (114()):106704 doi:10.1016/j.cct.2022.106704.

    PMID: 35149233
  48. 48

    Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review.

    Tascini G, Dell'Isola GB, Mencaroni E, et al.

    Frontiers in neurology 2022; (13()):817195 doi:10.3389/fneur.2022.817195.

    PMID: 35299616
  49. 49

    Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.

    Hurley EN, Ellaway CJ, Johnson AM, et al.

    Epilepsia 2022; (63(7)):1736-1747 doi:10.1111/epi.17247.

    PMID: 35364618
  50. 50

    Impact of a 12-month multifaceted neurological physiotherapy intervention on gross motor function in women with Rett syndrome.

    Kapel A, Kovacic T, Kos N, Velnar T

    Journal of integrative neuroscience 2022; (21(2)):59 doi:10.31083/j.jin2102059.

    PMID: 35364647
  51. 51

    Identification of a New Variant of PUF60 Gene: Case Presentation and Literature Review.

    Toader DO, Ursu R, Bacalbasa N, et al.

    Cancer diagnosis & prognosis 2021; (1(3)):213-219 doi:10.21873/cdp.10029.

    PMID: 35399315
  52. 52

    Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).

    Saldaris J, Leonard H, Jacoby P, et al.

    Journal of child neurology 2022; (37(6)):541-547 doi:10.1177/08830738221091044.

    PMID: 35422141
  53. 53

    Paradoxical Hyperexcitability in Disorders of Neurodevelopment.

    Antoine MW

    Frontiers in molecular neuroscience 2022; (15()):826679 doi:10.3389/fnmol.2022.826679.

    PMID: 35571370
  54. 54

    Delayed Ventricular Repolarization and Sodium Channel Current Modification in a Mouse Model of Rett Syndrome.

    Cheng H, Charles I, James AF, et al.

    International journal of molecular sciences 2022; (23(10)) doi:10.3390/ijms23105735.

    PMID: 35628543
  55. 55

    Advances in the pathogenesis of Rett syndrome using cell models.

    Lu S, Chen Y, Wang Z

    Animal models and experimental medicine 2022; (5(6)):532-541 doi:10.1002/ame2.12236.

    PMID: 35785421
  56. 56

    Gene Editing and Rett Syndrome: Does It Make the Cut?

    Coorey B, Haase F, Ellaway C, et al.

    The CRISPR journal 2022; (5(4)):490-499 doi:10.1089/crispr.2022.0020.

    PMID: 35881862
  57. 57

    Scoliosis in RETT Syndrome: A National Referral Centre Experience.

    Menachem S, Hershkovich O, Ackshota N, et al.

    Clinical spine surgery 2023; (36(2)):E75-E79 doi:10.1097/BSD.0000000000001381.

    PMID: 35994037
  58. 58

    Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage.

    Collins BE, Neul JL

    Neuropsychiatric disease and treatment 2022; (18()):2813-2835 doi:10.2147/NDT.S371483.

    PMID: 36471747
  59. 59

    Reduced Volumetric Bone Mineral Density of the Spine in Adolescent Rett Girls with Scoliosis.

    Tsaknakis K, Kreuzer JH, Metzger FL, et al.

    Children (Basel, Switzerland) 2022; (9(12)) doi:10.3390/children9121902.

    PMID: 36553345
  60. 60

    Interprofessional Collaboration Improves Quality of Life of a Young Adult With Rett Syndrome.

    Bullock JL, Gradick K, Proctor C, et al.

    Cureus 2023; (15(3)):e36921 doi:10.7759/cureus.36921.

    PMID: 37128525
  61. 61

    Trofinetide: First Approval.

    Keam SJ

    Drugs 2023; (83(9)):819-824 doi:10.1007/s40265-023-01883-8.

    PMID: 37191913
  62. 62

    Evaluation Tools Developed for Rett Syndrome.

    Lotan M, Downs J, Stahlhut M, Romano A

    Diagnostics (Basel, Switzerland) 2023; (13(10)) doi:10.3390/diagnostics13101708.

    PMID: 37238191
  63. 63

    Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.

    Neul JL, Percy AK, Benke TA, et al.

    Nature medicine 2023; (29(6)):1468-1475 doi:10.1038/s41591-023-02398-1.

    PMID: 37291210
  64. 64

    Rett-like Phenotypes in HNRNPH2-Related Neurodevelopmental Disorder.

    Gonzalez JN, Goldman S, Carter MT, Bain JM

    Genes 2023; (14(6)) doi:10.3390/genes14061154.

    PMID: 37372334
  65. 65

    Rett Syndrome: A Tale of Altered Genetics, Synaptic Plasticity, and Neurodevelopmental Dynamics.

    Oluigbo DC

    Cureus 2023; (15(7)):e41555 doi:10.7759/cureus.41555.

    PMID: 37554594
  66. 66

    Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need.

    Hudu SA, Elmigdadi F, Qtaitat AA, et al.

    Journal of clinical medicine 2023; (12(15)) doi:10.3390/jcm12155114.

    PMID: 37568516
  67. 67

    Multidisciplinary Management of Rett Syndrome: Twenty Years' Experience.

    Vilvarajan S, McDonald M, Douglas L, et al.

    Genes 2023; (14(8)) doi:10.3390/genes14081607.

    PMID: 37628658
  68. 68

    Teaching Requesting to Individuals with Rett Syndrome Using Alternative Augmentative Communication (AAC) Through Caregiver Coaching via Telehealth.

    Kolb RL, McComas JJ, Girtler SN, et al.

    Journal of developmental and physical disabilities 2023; (35(6)):1063-1090 doi:10.1007/s10882-023-09894-9.

    PMID: 38053943
  69. 69

    Rett and Rett-related disorders: Common mechanisms for shared symptoms?

    D'Mello SR

    Experimental biology and medicine (Maywood, N.J.) 2023; (248(22)):2095-2108 doi:10.1177/15353702231209419.

    PMID: 38057990
  70. 70

    The Efficacy of a Human-Ready miniMECP2 Gene Therapy in a Pre-Clinical Model of Rett Syndrome.

    Sadhu C, Lyons C, Oh J, et al.

    Genes 2023; (15(1)) doi:10.3390/genes15010031.

    PMID: 38254921
  71. 71

    Development of trofinetide for the treatment of Rett syndrome: from bench to bedside.

    Kennedy M, Glass L, Glaze DG, et al.

    Frontiers in pharmacology 2023; (14()):1341746 doi:10.3389/fphar.2023.1341746.

    PMID: 38318312
  72. 72

    Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.

    Moore R, Poulsen J, Reardon L, et al.

    Advances in therapy 2024; (41(4)):1305-1317 doi:10.1007/s12325-024-02782-4.

    PMID: 38378975
  73. 73

    Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials.

    Lopes AG, Loganathan SK, Caliaperumal J

    Brain sciences 2024; (14(2)) doi:10.3390/brainsci14020120.

    PMID: 38391695
  74. 74

    Normalized Clinical Severity Scores Reveal a Correlation between X Chromosome Inactivation and Disease Severity in Rett Syndrome.

    Merritt JK, Fang X, Caylor RC, et al.

    Genes 2024; (15(5)) doi:10.3390/genes15050594.

    PMID: 38790223
  75. 75

    Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome.

    Motil KJ, Beisang A, Smith-Hicks C, et al.

    Expert review of gastroenterology & hepatology 2024; (18(6)):227-237 doi:10.1080/17474124.2024.2368014.

    PMID: 38869952
  76. 76

    Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study.

    Percy AK, Neul JL, Benke TA, et al.

    Med (New York, N.Y.) 2024; (5(9)):1178-1189.e3 doi:10.1016/j.medj.2024.05.018.

    PMID: 38917793
  77. 77

    Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study.

    Percy AK, Neul JL, Benke TA, et al.

    Med (New York, N.Y.) 2024; (5(10)):1275-1281.e2 doi:10.1016/j.medj.2024.06.007.

    PMID: 39025065
  78. 78

    Rett Syndrome: The Emerging Landscape of Treatment Strategies.

    Percy AK, Ananth A, Neul JL

    CNS drugs 2024; (38(11)):851-867 doi:10.1007/s40263-024-01106-y.

    PMID: 39251501
  79. 79

    [Rett syndrome: from pathophysiology to developments in treatment].

    Cabal-Herrera AM, Beatty CW

    Medicina 2024; (84 Suppl 3()):45-49.

    PMID: 39331775
  80. 80

    LEDGF interacts with the NID domain of MeCP2 and modulates MeCP2 condensates.

    Lesire S, Lata R, Hoogvliets Y, et al.

    Structure (London, England : 1993) 2025; (33(1)):78-90.e6 doi:10.1016/j.str.2024.10.016.

    PMID: 39500316
  81. 81

    Rett syndrome.

    Gold WA, Percy AK, Neul JL, et al.

    Nature reviews. Disease primers 2024; (10(1)):84 doi:10.1038/s41572-024-00568-0.

    PMID: 39511247
  82. 82

    Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy.

    Camillo L, Pozzi M, Bernardo P, et al.

    Drug design, development and therapy 2024; (18()):5023-5040 doi:10.2147/DDDT.S383133.

    PMID: 39525048
  83. 83

    Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndrome.

    Percy AK, Ryther R, Marsh ED, et al.

    Med (New York, N.Y.) 2025; (6(6)):100608 doi:10.1016/j.medj.2025.100608.

    PMID: 40043705
  84. 84

    A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic Syndromes.

    Thom RP, Warren TL, Khan S, et al.

    Journal of child and adolescent psychopharmacology 2025; (35(4)):178-193 doi:10.1089/cap.2025.0023.

    PMID: 40138183
  85. 85

    Self-regulating gene therapy ameliorates phenotypes and overcomes gene dosage sensitivity in a mouse model of Rett syndrome.

    Ross PD, Gadalla KKE, Thomson SR, et al.

    Science translational medicine 2025; (17(792)):eadq3614 doi:10.1126/scitranslmed.adq3614.

    PMID: 40173263
  86. 86

    Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome.

    Postogna FM, Roggero OM, Biella F, Frasca A

    Brain research bulletin 2025; (227()):111386 doi:10.1016/j.brainresbull.2025.111386.

    PMID: 40378493
  87. 87

    MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping.

    Mietto M, Montanari S, Falzarano MS, et al.

    Biomolecules 2025; (15(5)) doi:10.3390/biom15050687.

    PMID: 40427580
  88. 88

    Bilingualism in the preserved speech variant of Rett syndrome: A longitudinal case study.

    Day RH, Cooper S, Sanoudaki E

    Clinical linguistics & phonetics 2026; (40(3)):207-226 doi:10.1080/02699206.2025.2508260.

    PMID: 40458919
  89. 89

    Clinical and functional outcomes in pediatric patients with Rett syndrome: a 15-year retrospective study.

    Ferreira MC, De Beir J, Barreto MI, et al.

    European journal of pediatrics 2025; (184(7)):465 doi:10.1007/s00431-025-06291-6.

    PMID: 40608138
  90. 90

    Communication Abilities, Assessment Procedures, and Intervention Approaches in Rett Syndrome: A Narrative Review.

    Voniati L, Papadopoulos A, Ziavra N, Tafiadis D

    Brain sciences 2025; (15(7)) doi:10.3390/brainsci15070753.

    PMID: 40722343
  91. 91

    Sleep Disorders in Children with Rett Syndrome.

    Harner C, Gaffey TA, Sullivan SS, et al.

    Children (Basel, Switzerland) 2025; (12(7)) doi:10.3390/children12070869.

    PMID: 40723062
  92. 92

    Communication and feeding skills in Rett syndrome: Case report.

    Voniati L, Georgiou R

    Journal of intellectual & developmental disability 2025; 1-9 doi:10.3109/13668250.2025.2568297.

    PMID: 41090289
  93. 93

    Epidemiology and Healthcare Resource Utilization of Rett Syndrome in Canada: The Ontario Experience.

    Bond S, Murray J, Datta AN, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2025; 1-7 doi:10.1017/cjn.2025.10475.

    PMID: 41267498
  94. 94

    A novel frameshift CUX2 variant in a patient with epilepsy and global developmental delay: Phenotypic and genotypic expansion.

    Romano F, Shams Nosrati MS, Madia F, et al.

    European journal of medical genetics 2026; (79()):105064 doi:10.1016/j.ejmg.2025.105064.

    PMID: 41344425
  95. 95

    Rett syndrome: a review of clinical manifestations and therapeutic approaches.

    Bricker K, Vaughn BV

    Frontiers in sleep 2024; (3()):1373489 doi:10.3389/frsle.2024.1373489.

    PMID: 41424498
  96. 96

    [Features of premorbid status in patients with Rett syndrome].

    Fedoseeva IF, Goncharenko VA, Goncharenko AV, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2026; (126(2)):136-143 doi:10.17116/jnevro2026126021136.

    PMID: 41782542